<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T23:36:23Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/24350" metadataPrefix="mods">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/24350</identifier><datestamp>2026-02-03T11:02:48Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><mods:mods xmlns:doc="http://www.lyncode.com/xoai" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Flores-López, María</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>García-Marchena, Nuria</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Araos Gómez, Pedro Fernando</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Requena-Ocaña, Nerea</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Porras-Perales, Oscar</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Torres-Galván, Sandra</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Suárez-Pérez, Juan</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Pizarro Lozano, Nieves</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>De la Torre, Rafael</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Rubio, Gabriel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Ruiz-Ruiz, Juan Jesús</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Rodriguez-de-Fonseca, Fernando</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Serrano, Antonia</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Pavón-Morón, Francisco Javier</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2022-06-13T09:28:17Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2022-06-13T09:28:17Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2022-04-30</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="citation">Flores-López M, García-Marchena N, Araos P, Requena-Ocaña N, Porras-Perales O, Torres-Galván S, Suarez J, Pizarro N, de la Torre R, Rubio G, Ruiz-Ruiz JJ, Rodríguez de Fonseca F, Serrano A, Pavón-Morón FJ. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders. Brain Sciences. 2022; 12(5):588. https://doi.org/10.3390/brainsci12050588</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/10630/24350</mods:identifier>
   <mods:identifier type="doi">10.3390/brainsci12050588</mods:identifier>
   <mods:abstract>Preclinical evidence suggests a main role of lysophosphatidic acid (LPA) signaling in&#xd;
drug addiction. Recently, we reported alterations in the plasma concentrations of LPA species in&#xd;
patients with alcohol use disorder (AUD). As there are sex differences in drug addiction, the main&#xd;
aim of the present study was to investigate whether relevant LPA species (16:0-LPA, 18:0-LPA, 18:1-&#xd;
LPA, 18:2-LPA and 20:4-LPA) were associated with sex and/or substance use disorder (SUD). This&#xd;
exploratory study was conducted in 214 abstinent patients with lifetime SUD, and 91 healthy control&#xd;
subjects. The SUD group was divided according to the diagnosis of AUD and/or cocaine use disorder&#xd;
(CUD). Participants were clinically assessed, and plasma samples were collected to determine LPA&#xd;
species and total LPA. We found that LPA concentrations were significantly affected by sex, and&#xd;
women showed higher concentrations than men. In addition, there were significantly lower 16:0-LPA,&#xd;
18:2-LPA and total LPA concentrations in patients with SUD than in controls. Namely, patients with&#xd;
CUD and AUD + CUD showed lower LPA concentrations than controls or patients with AUD. In&#xd;
conclusion, our data suggest that LPA species could be potential biomarkers for SUD in women and&#xd;
men, which could contribute to a better stratification of these patients in treatment programs.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
   <mods:subject>
      <mods:topic>Drogas</mods:topic>
   </mods:subject>
   <mods:titleInfo>
      <mods:title>Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods>
</metadata></record></GetRecord></OAI-PMH>